Development of inactivated poliovirus vaccine derived from Sabin strains

被引：39

作者：

Simizu, B ^{[1
]}

Abe, S ^{[1
]}

Yamamoto, H ^{[1
]}

Tano, Y ^{[1
]}

Ota, Y ^{[1
]}

Miyazawa, M ^{[1
]}

Horie, H ^{[1
]}

Satoh, K ^{[1
]}

Wakabayashi, K ^{[1
]}

机构：

[1] Japan Poliomyelitis Res Inst, Tokyo 1890003, Japan

来源：

BIOLOGICALS | 2006年 / 34卷 / 02期

关键词：

IPV; Sabin strains; D-antigen; immunogenicity;

D O I：

10.1016/j.biologicals.2006.02.010

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

In the course of Sabin-inactivated poliovirus vaccine (S-IPV) development, we have established high-yield virus production techniques based on Vero cell micro-carrier cultures. Development of specific ELISA tests to quantify the antigen content of S-IPV has been achieved. To adjust the immunogenicity of S-IPV so as to be comparable with the conventional-IPV, a new formulation was determined using a potency test using rats. The reformulated S-IPV was shown to be efficacious for the immunization of monkeys. (c) 2006 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

引用

页码：151 / 154

页数：4

共 50 条

[1] Development of inactivated poliovirus vaccine from Sabin strains: A progress report
Okayasu, Hiromasa
Sein, Carolyn
Hamidi, Ahd
Bakker, Wilfried A. M.
Sutter, Roland W.
BIOLOGICALS, 2016, 44 (06) : 581 - 587
[2] Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan
Shimizu, Hiroyuki
VACCINE, 2016, 34 (16) : 1975 - 1985
[3] Development of Inactivated Polio Vaccine (IPV) Derived from Attenuated Sabin Strains
Bakker, Wilfried A. M.
Thomassen, Yvonne E.
van 't Oever, Aart G.
Westdijk, Janny
van Oijen, Monique G. C. T.
Kersten, Gideon F. A.
van der Pol, Leo A.
Hertroys, Rudy
van den Heuvel, Nico
Hendriks, Jan
PROCEEDINGS OF THE 21ST ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR ANIMAL CELL TECHNOLOGY (ESACT), 2009, 2012, 5 : 667 - 670
[4] Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine
Shin, Woo-Jin
Hara, Daiki
Gbormittah, Francisca
Chang, Hana
Chang, Byeong S.
Jung, Jae U.
MBIO, 2018, 9 (06):
[5] Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains
Verdijk, Pauline
Rots, Nynke Y.
Bakker, Wilfried A. M.
EXPERT REVIEW OF VACCINES, 2011, 10 (05) : 635 - 644
[6] Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains
Tano, Yoshio
Shimizu, Hiroyuki
Martin, Javier
Nishimura, Yorihiro
Simizu, Bunsiti
Miyamura, Tatsuo
VACCINE, 2007, 25 (41) : 7041 - 7046
[7] Physicochemical Characterization of Sabin Inactivated Poliovirus Vaccine for Process Development
Torisu, Tetsuo
Shikama, Saori
Nakamura, Kuniaki
Enomoto, Kanta
Maruno, Takahiro
Mori, Asuka
Uchiyama, Susumu
Satou, Tatsuki
JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (05) : 2121 - 2129
[8] QUANTITATION OF D-ANTIGEN CONTENT IN INACTIVATED POLIOVIRUS VACCINE DERIVED FROM WILD-TYPE OR SABIN STRAINS
SAWYER, LA
MCINNIS, J
ALBRECHT, P
BIOLOGICALS, 1993, 21 (02) : 169 - 177
[9] CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus
Yang, Chunting
Shi, Huiying
Zhou, Jun
Liang, Yanwen
Xu, Honglin
VACCINE, 2009, 27 (47) : 6558 - 6563
[10] A national reference for inactivated polio vaccine derived from Sabin strains in Japan
Shirato, Haruko
Someya, Yuichi
Ochiai, Masaki
Horiuchi, Yoshinobu
Takahashi, Motohide
Takeda, Naokazu
Wakabayashi, Kengo
Ouchi, Yasumitsu
Ota, Yoshihiro
Tano, Yoshio
Abe, Shinobu
Yamazaki, Shudo
Wakita, Takaji
VACCINE, 2014, 32 (40) : 5163 - 5169

← 1 2 3 4 5 →